NAVAL DAVER to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications NAVAL DAVER has written about Randomized Controlled Trials as Topic.
Connection Strength
0.253
-
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges. Cancer Discov. 2020 04; 10(4):506-525.
Score: 0.096
-
CPX-351 (vyxeos) in AML. Leuk Lymphoma. 2020 02; 61(2):288-297.
Score: 0.094
-
Harnessing Apoptosis in AML. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S61-S64.
Score: 0.025
-
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase. Cancer. 2018 03 15; 124(6):1160-1168.
Score: 0.021
-
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors. Cancer. 2016 Jan 15; 122(2):238-48.
Score: 0.018